Differences in binding of epidermal growth factor to liver membranes of TCDD-resistant and TCDD-sensitive rats after a single dose of TCDD

By Khalifa M.A.   Hodhod O.A.   Zaki M.A.   Cernia E.   Libori R.   Marconi W.   Soro S.   Tuomisto J.   Sewall C.H.   Unkila M.   Pohjanvirta R.   Clark G.C.   Viluksela M.   Rozman K.   Lucier G.W.  

Environmental Toxicology and Pharmacology, Vol. 1, Iss. 2, 1996-04 ,pp. : 109-116

Elsevier

Access to resources Recommend Favorite

Cytotoxic and Antitumor Activities of Doxorubicin Conjugates with the Epidermal Growth Factor and its Receptor-binding Fragment

By Lutsenko S.V.   Feldman N.B.   Severin S.E.  

Journal of Drug Targeting, Vol. 10, Iss. 7, 2002-01 ,pp. : 567-571

Informa Healthcare

Access to resources Recommend Favorite

Intraarticular injection of heparin‐binding insulin‐like growth factor 1 sustains delivery of insulin‐like growth factor 1 to cartilage through binding to chondroitin sulfate

By  

Arthritis & Rheumatism, Vol. 62, Iss. 12, 2010-12 ,pp. : 3686-3694

John Wiley & Sons Inc

Access to resources Recommend Favorite

Video observations on human blastocyst hatching

By Menezes Judith   Gunasheela Sulochana   Sathananthan Henry  

Reproductive BioMedicine Online, Vol. 7, Iss. 2, 2003-09 ,pp. : 217-218

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Binding of gefitinib, an inhibitor of epidermal growth factor receptor-tyrosine kinase, to plasma proteins and blood cells: in vitro and in cancer patients

By Li Jing   Brahmer Julie   Messersmith Wells   Hidalgo Manuel   Baker Sharyn  

Investigational New Drugs, Vol. 24, Iss. 4, 2006-07 ,pp. : 291-297

Springer Publishing Company

Access to resources Recommend Favorite